DN Decision Briefs
Understand the conditions behind a platform claim. Follow the sources, see what remains unknown and save the exact evidence version you used.
Research directory
These are documentation reviews, not live execution tests or safety ratings. Review status is evaluated on 2026-11-03; it does not indicate live monitoring.
Search this directory on your device. Search terms are not sent to DN analytics or saved in the URL.
Showing 20 of 20 research briefs.
The final three-way refresh sharpens product-scope and cost differences without producing a winner. GMX adds more explicit pool-impact/funding/borrowing controls, MUX now quantifies native V3 fees and borrowing, and SynFutures' current 2026 stack is broader than the historical V3 snapshot.
Within review window
Reviewed 2026-10-24 · v1.1.0
Current documentation sharpens the comparison rather than producing an overall winner. Paradex Retail/Pro routing now has explicit speed bumps, limits and fee schedules; GRVT MAM now exposes CVRs, 9-tier trading fees and repayment charges. Both still leave live execution, permissions and user-specific eligibility unmeasured.
Within review window
Reviewed 2026-10-22 · v1.1.0
Current documentation sharpens the comparison without producing an overall winner. MYX now exposes concrete rating/VIP fee tables and a 3,000 USD Profit Lock appeal bond; Aster now exposes headline Pro fees, Single-Asset collateral, Multi-Asset auto-exchange/interest terms and current TWAP limits.
Within review window
Reviewed 2026-10-23 · v1.1.0
Current documentation sharpens the comparison without producing a winner. ApeX Omni now exposes broader cross-collateral and API limits; EVEDEX clarifies hybrid gasless trading, broader markets and cashback timing; SAI now quantifies taker, trigger, rapid-close, borrowing and liquidation charges.
Within review window
Reviewed 2026-10-24 · v1.1.0
Current documentation still supports a mode-first comparison, but both sides now expose more explicit conditionality: Hyperliquid portfolio margin has documented eligibility, caps, LTV and borrow/earn mechanics, while Lighter now distinguishes core Lighter collateral from a separate Robinhood Chain Lighter collateral table. No live cheapest, fastest or safest-platform conclusion is supported.
Within review window
Reviewed 2026-10-22 · v1.1.0
ApeX Omni still separates funding from trading balances and requires distinct API/ZkLink signing controls. Current API docs now specify 8 cross-collateral assets, hourly funding, explicit private/order rate limits and separate actual-fee vs limit-fee fields.
Within review window
Reviewed 2026-10-24 · v1.1.0
SynFutures still combines orderbook and AMM liquidity for perpetuals, but its 2026 product stack is broader than the original snapshot. Current official material references a newer mainnet architecture, API access and deployments including Base, Blast and Monad, so product and network scope must be checked before applying older workflow assumptions.
Within review window
Reviewed 2026-10-24 · v1.1.0
MUX remains a suite that combines aggregator routing with native V3. Current docs now quantify native V3 costs more clearly, including 0.06% open/close position fees, hourly borrowing based on an 8% base annualized rate that can rise toward 40–50%, and a 0.06% liquidation fee.
Within review window
Reviewed 2026-10-24 · v1.1.0
EVEDEX still settles reviewed perpetuals in USDT and charges on executed notional, but current docs now show a much broader market set, hybrid gasless trading, next-day USDT cashback and expanded smart-account onboarding routes.
Within review window
Reviewed 2026-10-24 · v1.1.0
SAI remains gasless on Nibiru for trading, but its current documentation now quantifies the full fee stack: 0.05% base taker, 0% maker, 0.01% trigger, variable borrowing, rapid-close penalties and a 10% liquidation penalty on remaining collateral.
Within review window
Reviewed 2026-10-24 · v1.1.0
GRVT still separates Single-Asset and Multi-Asset Margin, with USDT settlement and USDC collateral support under MAM. Current docs now specify CVRs, hourly borrowing, current 9-tier trading fees and MAM repayment charges, while withdrawal pages still differ slightly on route-fee presentation.
Within review window
Reviewed 2026-10-22 · v1.1.0
MYX V2 still ties maker/taker treatment to market imbalance rather than order type. Current docs now expose full rating/VIP fee tables and make Profit Lock dispute economics more concrete, including a 3,000 USD LP appeal bond.
Within review window
Reviewed 2026-10-23 · v1.1.0
Aster Pro perpetuals still separate cross, isolated and multi-asset risk, but current docs now provide concrete 0.01% maker / 0.035% taker headline rates, Single-Asset collateral of USDT and USD1, Multi-Asset auto-exchange triggers and a documented 4% annualized negative-balance rate.
Within review window
Reviewed 2026-10-23 · v1.1.0
Account mode still controls how balances support perpetual trading. Current portfolio-margin documentation adds explicit eligibility thresholds, asset caps, LTVs, automated borrowing and idle-asset yield; unified and portfolio modes also carry a documented daily action limit.
Within review window
Reviewed 2026-10-22 · v1.1.0
Standard accounts currently have zero maker/taker fees across perpetual and spot markets, while Plus and Premium/Advanced use paid tiers. Multi-asset margin remains UTA-only and now documents separate collateral parameters for core Lighter and Robinhood Chain Lighter, while the page still contains conflicting spot-availability language.
Within review window
Reviewed 2026-10-22 · v1.1.0
Paradex still classifies orders by submission method rather than permanent user type. Current docs make the trade-offs explicit: Retail orders have 300 ms order/cancel speed bumps, much lower rate limits, zero fees across Perps/Spot/Options, RPI access and queue priority, while Pro orders use the API fee schedule and no speed bump.
Within review window
Reviewed 2026-10-22 · v1.1.0
GMX V2 still separates funding routes, market/pool collateral and execution. Current docs now make pool-specific price-impact caps, continuous/event-driven funding and borrowing, conditional margin deposits, network-fee handling and delegated-subaccount controls more explicit.
Within review window
Reviewed 2026-10-24 · v1.1.0
DAI is documented as close-only on Arbitrum and Polygon. New-position collateral varies by network; Arbitrum also lists GNS. Verify the deployment and full cost breakdown.
Within review window
Reviewed 2026-10-22 · v1.1.0
Veranta documents USDC margin on Base and session-based trading permissions. Its fee pages disagree on maker rates and Upside borrowing costs. Treat zero-commission claims as product-specific; no definitive total-cost comparison or live security assessment is established.
Within review window
Reviewed 2026-10-22 · v1.1.0
Compare documented conditions without declaring a winner. Both snapshots describe USDC on Base, but Veranta fee sources conflict and neither brief measures comparable live execution or permission safety.
Within review window
Reviewed 2026-10-22 · v1.2.0
Provider statements link to their sources. Unknowns stay visible instead of becoming scores.
Network, collateral, product mode and cost assumptions matter. Incomplete evidence cannot support a cheapest-platform ranking.
Download the evidence or share a versioned link. A comparison receipt includes all underlying source snapshots.
